|
Originally published In Press as doi:10.1074/jbc.M307310200 on October 1, 2003
J. Biol. Chem., Vol. 278, Issue 50, 50563-50571, December 12, 2003
Osteocrin, a Novel Bone-specific Secreted Protein That Modulates the Osteoblast Phenotype*
Gethin Thomas ¶,
Pierre Moffatt ¶,
Patrick Salois¶,
Marie-Hélène Gaumond¶,
Rock Gingras¶,
Éric Godin¶,
Dengshun Miao||,
David Goltzman||, and
Christian Lanctôt¶
From the
¶Phenogene Therapeutics Inc., 416 de Maisonneuve West, Suite 1020, Montreal, Quebec H3A 1L2, Canada, and the ||Calcium Research Laboratory, McGill University Health Centre, McGill University, Montreal, Quebec H3A 1A1, Canada
Although a number of secreted factors have been demonstrated to be bone regulators, none of these are unique to bone. Using a viral-based signal-trap strategy we have identified a novel gene we have termed "osteocrin." A 1280-bp mRNA encodes osteocrin producing a mature protein of 103 amino acids with a molecular mass of 11.4 kDa. Osteocrin shows no homology with any known gene except for two conserved sequence motifs reminiscent of dibasic cleavage sites found in peptide hormone precursors. Immunofluorescence and Western blot analysis confirmed the secretory nature of osteocrin. Two protein species were identified in the medium of cells overexpressing osteocrin, a full-length 11.4 kDa species and a processed 5 kDa species. Mutation of the 76KKKR79 dibasic cleavage site abolished the appearance of this smaller osteocrin fragment. By in situ hybridization in mouse embryos, osteocrin was expressed specifically in Cbfa-1-positive, osteocalcin-negative osteoblasts. Immunohistochemistry on adult mouse bone showed osteocrin localization in osteoblasts and young osteocytes. By Northern blot analysis, osteocrin expression was only detected in bone, expression peaking just after birth and decreasing markedly with age. In primary osteoblastic cell cultures osteocrin expression coincided with matrix formation then decreased in very mature cultures. Treatment of cultures with 1,25-dihydroxyvitamin D3 resulted in a rapid dose-dependent down-regulation of osteocrin expression, suggesting direct regulation. Chronic treatment of primary cultures with osteocrin-conditioned media inhibited mineralization and reduced osteocalcin and alkaline phosphatase expression. These results suggest that osteocrin represents a novel, unique vitamin D-regulated bone-specific protein that appears to act as a soluble osteoblast regulator.
Received for publication, July 8, 2003
, and in revised form, September 27, 2003.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EBI Data Bank with accession number(s) AY395730, AY398681, AY398682, and AY398683.
* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
These authors contributed equally to this work.
To whom correspondence should be addressed: Phenogene Therapeutics Inc., 416 de Maisonneuve West, Suite 1020, Montreal, Quebec, H3A 1L2, Canada. Tel.: 514-288-9099; Fax: 514-288-1111; E-mail: gthomas{at}phenogene.com.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Kita, H. Nishizawa, Y. Okuno, M. Tanaka, A. Yasui, M. Matsuda, Y. Yamada, and I. Shimomura
Competitive binding of musclin to natriuretic peptide receptor 3 with atrial natriuretic peptide
J. Endocrinol.,
May 1, 2009;
201(2):
287 - 295.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. C R Prickett, G. K Barrell, M. Wellby, T. G Yandle, A M. Richards, and E. A Espiner
Effect of sex steroids on plasma C-type natriuretic peptide forms: stimulation by oestradiol in lambs and adult sheep
J. Endocrinol.,
December 1, 2008;
199(3):
481 - 487.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Moffatt, G. Thomas, K. Sellin, M.-C. Bessette, F. Lafreniere, O. Akhouayri, R. St-Arnaud, and C. Lanctot
Osteocrin Is a Specific Ligand of the Natriuretic Peptide Clearance Receptor That Modulates Bone Growth
J. Biol. Chem.,
December 14, 2007;
282(50):
36454 - 36462.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Mirabeau, E. Perlas, C. Severini, E. Audero, O. Gascuel, R. Possenti, E. Birney, N. Rosenthal, and C. Gross
Identification of novel peptide hormones in the human proteome by hidden Markov model screening
Genome Res.,
March 1, 2007;
17(3):
320 - 327.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Zhou, N. Deeb, C. M. Evock-Clover, A. D. Mitchell, C. M. Ashwell, and S. J. Lamont
Genome-Wide Linkage Analysis to Identify Chromosomal Regions Affecting Phenotypic Traits in the Chicken. III. Skeletal Integrity
Poult. Sci.,
February 1, 2007;
86(2):
255 - 266.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. R. Potter, S. Abbey-Hosch, and D. M. Dickey
Natriuretic Peptides, Their Receptors, and Cyclic Guanosine Monophosphate-Dependent Signaling Functions
Endocr. Rev.,
February 1, 2006;
27(1):
47 - 72.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Bord, D. C. Ireland, P. Moffatt, G. P. Thomas, and J. E. Compston
Characterization of Osteocrin Expression in Human Bone
J. Histochem. Cytochem.,
October 1, 2005;
53(10):
1181 - 1187.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Nishizawa, M. Matsuda, Y. Yamada, K. Kawai, E. Suzuki, M. Makishima, T. Kitamura, and I. Shimomura
Musclin, a Novel Skeletal Muscle-derived Secretory Factor
J. Biol. Chem.,
May 7, 2004;
279(19):
19391 - 19395.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|